Hidradenitis Suppurativa
Hidradenitis
Apocrine Glands
Taboo
Acquired Hyperostosis Syndrome
Acne Vulgaris
Pyoderma Gangrenosum
Perineum
Letter: Neutrophilic eccrine hidroadenitis with atypical findings. (1/2)
Neutrophilic eccrine hidradenitis (NEH) was originally described as a distinctive dermatosis occurring in patients undergoing chemotherapy, especially associated with the use of cytarabine in the treatment of acute myelogenous leukemia (AML). This disorder is characterized by a neutrophilic infiltrate around the eccrine glands and coils and is associated with necrosis. However, atypical findings in the histology have been reported. To the best of our knowledge, leukocytoclastic vasculitis has not been described in association with NEH. We hypothesize that a toxic effect of cytarabine may damage the vessel wall to some extent, causing a vasculitic phenomenon. (+info)Neutrophilic eccrine hidradenitis: a new culprit-carbamazepine. (2/2)
(+info)Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that typically affects areas of the body where there are sweat glands, such as the armpits, groin, and buttocks. The main features of HS are recurrent boil-like lumps or abscesses (nodules) that form under the skin. These nodules can rupture and drain pus, leading to painful, swollen, and inflamed lesions. Over time, these lesions may heal, only to be replaced by new ones, resulting in scarring and tunnel-like tracts (sinus tracts) beneath the skin.
HS is a debilitating condition that can significantly impact an individual's quality of life, causing physical discomfort, emotional distress, and social isolation. The exact cause of HS remains unclear, but it is thought to involve a combination of genetic, hormonal, and environmental factors. Treatment options for HS include topical and oral antibiotics, biologic therapies, surgical interventions, and lifestyle modifications, such as weight loss and smoking cessation.
Sweat gland diseases are medical conditions that affect the functioning or structure of sweat glands, leading to excessive sweating (hyperhidrosis), lack of sweating (anhydrosis), or abnormal sweating (e.g., foul-smelling sweat). There are two main types of sweat glands in humans: eccrine glands, which produce a watery sweat that helps regulate body temperature, and apocrine glands, which are located in the armpits and groin and produce a thicker, milky sweat that can mix with bacteria on the skin and cause body odor.
Some examples of sweat gland diseases include:
1. Hidradenitis suppurativa: A chronic skin condition characterized by inflammation and infection of the apocrine glands, leading to the formation of abscesses, nodules, and sinus tracts.
2. Primary focal hyperhidrosis: A condition that causes excessive sweating in specific areas of the body, such as the armpits, hands, feet, or face, without any underlying medical cause.
3. Secondary generalized hyperhidrosis: Excessive sweating that affects the entire body and is caused by an underlying medical condition, such as diabetes, thyroid disease, or obesity.
4. Cystic adenoma of the axilla: A benign tumor that arises from the apocrine glands in the armpit.
5. Eccrine nevus: A rare congenital condition characterized by an increased number of eccrine glands in a localized area of the skin, leading to excessive sweating.
6. Fox-Fordyce disease: A chronic inflammatory disorder that affects the apocrine glands, causing itchy papules and pustules in the armpits and groin.
7. Pachyonychia congenita: A rare genetic disorder characterized by thickened nails, palmoplantar keratoderma, and abnormalities of the eccrine glands, leading to excessive sweating and odor production.
Hidradenitis is a chronic skin condition characterized by the inflammation and infection of the apocrine glands, which are found in areas of the body with sweat glands such as the armpits, groin, and buttocks. This condition can cause painful bumps or abscesses to form under the skin, which may rupture and drain pus. In severe cases, hidradenitis can lead to scarring and tunneling of the skin. The exact cause of this condition is not fully understood, but it is believed to be related to hormonal factors, genetics, and immune system dysfunction. Treatment options for hidradenitis include antibiotics, anti-inflammatory medications, and surgical intervention in severe cases.
Apocrine glands are a type of sweat gland found in mammals, including humans. They are most concentrated in areas with dense hair follicles, such as the axillae (armpits) and genital region. These glands release their secretions into the hair follicle, which then reaches the skin surface through the pores.
Apocrine glands become active during puberty and are associated with the production of odorous sweat. The sweat produced by apocrine glands is initially odorless but can acquire a smell when it comes into contact with bacteria on the skin surface, which break down the organic compounds in the sweat. This can contribute to body odor.
It's important to note that while apocrine glands are often associated with body odor, they do not cause body odor directly. The odor is produced when the sweat from apocrine glands mixes with bacteria on the skin surface.
In medical terminology, 'taboo' does not have a specific definition as it is more commonly used in anthropological or sociological contexts. However, generally speaking, a taboo refers to a social or religious custom that prohibits something considered sacred, holy, or forbidden. It often involves behaviors, words, or subjects that are considered offensive, shocking, or dangerous, and are avoided or punished in certain cultures or societies. In a medical setting, healthcare professionals may encounter taboos related to cultural practices, patient beliefs, or sensitive topics that require cultural competence and sensitivity to address appropriately.
Suppuration is the process of forming or discharging pus. It is a condition that results from infection, tissue death (necrosis), or injury, where white blood cells (leukocytes) accumulate to combat the infection and subsequently die, forming pus. The pus consists of dead leukocytes, dead tissue, debris, and microbes (bacteria, fungi, or protozoa). Suppuration can occur in various body parts such as the lungs (empyema), brain (abscess), or skin (carbuncle, furuncle). Treatment typically involves draining the pus and administering appropriate antibiotics to eliminate the infection.
Acquired hyperostosis syndrome is not a widely recognized medical term, and it may refer to several different conditions that involve abnormal bone growth or hardening. One possible condition that might be referred to as acquired hyperostosis syndrome is diffuse idiopathic skeletal hyperostosis (DISH).
Diffuse idiopathic skeletal hyperostosis is a non-inflammatory condition that affects the spine and other parts of the body. It is characterized by the calcification and ossification of ligaments and entheses, which are the sites where tendons or ligaments attach to bones. This process can lead to the formation of bony spurs or growths, called osteophytes, along the spine and other affected areas.
The exact cause of DISH is not known, but it is more common in older adults, males, and people with certain medical conditions such as diabetes and obesity. The symptoms of DISH can vary widely depending on the severity and location of the bone growths. Some people may experience stiffness, pain, or limited mobility in the affected areas, while others may have no symptoms at all.
It is important to note that there are many other conditions that can cause abnormal bone growth or hardening, so a proper medical evaluation is necessary to determine the underlying cause of any symptoms. If you have concerns about acquired hyperostosis syndrome or any other medical condition, you should speak with your healthcare provider for further guidance.
Acne vulgaris is a common skin condition characterized by the formation of various types of blemishes on the skin, such as blackheads, whiteheads, papules, pustules, and cysts or nodules. These lesions typically appear on areas of the body that have a high concentration of sebaceous glands, including the face, neck, chest, back, and shoulders.
Acne vulgaris occurs when hair follicles become clogged with dead skin cells and excess oil (sebum) produced by the sebaceous glands. This blockage provides an ideal environment for bacteria, particularly Propionibacterium acnes, to multiply, leading to inflammation and infection. The severity of acne vulgaris can range from mild with only a few scattered comedones (blackheads or whiteheads) to severe cystic acne, which can cause significant scarring and emotional distress.
The exact causes of acne vulgaris are not fully understood, but several factors contribute to its development, including:
1. Hormonal changes during puberty, menstruation, pregnancy, or due to conditions like polycystic ovary syndrome (PCOS)
2. Genetic predisposition
3. Use of certain medications, such as corticosteroids and lithium
4. Excessive production of sebum due to overactive sebaceous glands
5. Accumulation of dead skin cells that clog pores
6. Bacterial infection (particularly Propionibacterium acnes)
7. Inflammation caused by the body's immune response to bacterial infection and clogged pores
Treatment for acne vulgaris depends on its severity and can include over-the-counter or prescription topical treatments, oral medications, chemical peels, light therapies, or even hormonal therapies in some cases. It is essential to seek professional medical advice from a dermatologist or healthcare provider to determine the most appropriate treatment plan for individual needs.
Pyoderma gangrenosum is a rare, inflammatory skin condition that typically begins as a small pustule or blister, which then rapidly progresses to form painful ulcers with a characteristic violaceous (bluish-purple) undermined border. The etiology of pyoderma gangrenosum is not entirely clear, but it's often associated with an underlying systemic disease, such as inflammatory bowel disease, rheumatoid arthritis, or hematologic disorders.
The pathophysiology of pyoderma gangrenosum involves a dysregulated immune response and neutrophil-mediated tissue damage. Diagnosis is often based on the clinical presentation and exclusion of other conditions with similar lesions. Treatment typically includes systemic immunosuppressive therapy, such as corticosteroids, cyclosporine, or biologic agents, along with local wound care to promote healing and prevent infection.
It's important to note that pyoderma gangrenosum can be a challenging condition to manage, and a multidisciplinary approach involving dermatologists, internists, and surgeons may be necessary for optimal care.
The perineum is the region between the anus and the genitals. In anatomical terms, it refers to the diamond-shaped area located in the lower part of the pelvis and extends from the coccyx (tailbone) to the pubic symphysis, which is the joint in the front where the two pubic bones meet. This region contains various muscles that support the pelvic floor and contributes to maintaining urinary and fecal continence. The perineum can be further divided into two triangular regions: the urogenital triangle (anterior) and the anal triangle (posterior).
Dermatologic agents are medications, chemicals, or other substances that are applied to the skin (dermis) for therapeutic or cosmetic purposes. They can be used to treat various skin conditions such as acne, eczema, psoriasis, fungal infections, and wounds. Dermatologic agents include topical corticosteroids, antibiotics, antifungals, retinoids, benzoyl peroxide, salicylic acid, and many others. They can come in various forms such as creams, ointments, gels, lotions, solutions, and patches. It is important to follow the instructions for use carefully to ensure safety and effectiveness.
The term "axilla" is used in anatomical context to refer to the armpit region, specifically the space located lateral to the upper part of the chest wall and medial to the upper arm. This area contains a number of important structures such as blood vessels, nerves, and lymph nodes, which play a critical role in the health and functioning of the upper limb. Understanding the anatomy of the axilla is essential for medical professionals performing various procedures, including surgeries and injections, in this region.
Hidradenitis
Hidradenitis suppurativa
Recurrent palmoplantar hidradenitis
Neutrophilic eccrine hidradenitis
Fistula
Clindamycin
Pharmacodynamics of spironolactone
Nintendo thumb
Boil
Cyproterone acetate
Finasteride
Sitting disability
Intermammary cleft
Bilophila wadsworthia
Resorcinol
Retrospective diagnosis
List of autoimmune diseases
Clascoterone
Rifampicin
Adalimumab
Bimekizumab
Acne
Extended cycle combined hormonal contraceptive
Metformin
Antiandrogen
TNF inhibitor
Vulva
Anaerobic infection
Progestogen (medication)
HFE H63D gene mutation
Hidradenitis - Wikipedia
Hidradenitis suppurativa: MedlinePlus Genetics
Fast Five Quiz: Hidradenitis Suppurativa Management
Hidradenitis Suppurativa Differential Diagnoses
Bacteria in Hidradenitis Suppurativa Support Antibiotic Use
Hidradenitis suppurativa and other diseases
Hidradenitis Suppurativa and Infections: Get the Facts
When Hidradenitis Involves the Bone - Hidradenitis Suppurativa
The gut microbiome and hidradenitis suppurativa: What is the link?
Hidradenitis suppurativa and risk of adverse cardiovascular events, death | ScienceDaily
Quick Quiz: Hidradenitis Suppurativa (HS) - Quick Quiz: Hidradenitis Suppurativa (HS)
Exercising if You Have Hidradenitis Suppurativa
Hidradenitis Suppurativa Awareness Week: Getting Involved
hidradenitis 5 -f.jpg - ASCCP
Hidradenitis Suppurativa: From Diagnosis to Treatment - Nova Science Publishers
Top Remedies for Hidradenitis Suppurativa
Jennifer Hsiao, MD: JAK Inhibitors for Hidradenitis Suppurativa
What Getting Treatment For Hidradenitis Suppurativa Is *Really* Like | Thought Catalog
Bacterial Pathogens Associated with Hidradenitis Suppurativa, France - Volume 20, Number 12-December 2014 - Emerging Infectious...
Fast Five Quiz: Hidradenitis Suppurativa
Novartis Cosentyx® shows clinically meaningful symptom improvements in patients with hidradenitis suppurativa in pivotal Phase...
Hidradenitis Suppurativa Responsive to TNF Inhibitor Therapy - MPR
Obstacles to Early Diagnosis and Treatment of Hidradenitis Suppurativa: Current Perspectives on Improving Clinical Management
Fast Five Quiz: Hidradenitis Suppurativa Diagnosis
Uniting with the Community in Recognition of Hidradenitis Suppurativa Awareness Week | UCB
Izokibep Falls Short of Primary Endpoint for Hidradenitis Suppurativa Patients
Hidradenitis behandeling - Medi Skin Care
A review of use of the word 'flare' in hidradenitis suppurativa studies
A Skin Mystery - Why a Disease Called Hidradenitis Suppurativa (HS) Is So Hard to Identify
Cross-sectional study identifies lower risk of Staphylococcus aureus nasal colonisation in Danish blood donors with...
Causing hidradenitis suppurativa1
- Genetic factors clearly play a role in causing hidradenitis suppurativa. (medlineplus.gov)
Moderate to severe hidradenitis5
- The surgical management of moderate to severe hidradenitis suppurativa affecting the axilla is explored in the context of the excision and reconstructive techniques available. (novapublishers.com)
- Basel, September 10, 2022 - Novartis announced the results from two pivotal, Phase III studies (SUNSHINE and SUNRISE), in which Cosentyx ® (secukinumab) demonstrated rapid and sustained relief from the common clinical signs and symptoms of moderate-to-severe hidradenitis suppurativa (HS) with a favorable safety profile 5,6 . (novartis.com)
- Acelyrin Inc. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa. (consultantlive.com)
- Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced positive top-line results from its global Phase 2 MIRA trial evaluating the efficacy and safety of the Nanobody ® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS). (pipelinereview.com)
- By clicking this link, you'll be leaving HSdiseasesource.com and going to a site with information about a prescription treatment option for moderate to severe hidradenitis suppurativa. (hsdiseasesource.com)
Associated with hidradenitis suppurativa2
- Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. (wikipedia.org)
- Researchers are working to determine whether additional genes, particularly those that provide instructions for making other γ-secretase components, are also associated with hidradenitis suppurativa. (medlineplus.gov)
European Hidradenitis Suppurativa Foundation4
- 5 European Hidradenitis Suppurativa Foundation e.V., Dessau, Germany. (nih.gov)
- 6th Conference of the European Hidradenitis Suppurativa Foundation e.V. (sidemast.org)
- welcome to the 6th Conference of the European Hidradenitis Suppurativa Foundation. (sidemast.org)
- EHSF2017 - Programma Scientifico Programma Scientifico del 6th Conference of the European Hidradenitis Suppurativa Foundation e.V. (sidemast.org)
Severe hidradenitis suppurativa1
- Blok JL, Spoo JR, Leeman FW, Jonkman MF, Horváth B. Skin-Tissue-sparing Excision with Electrosurgical Peeling (STEEP): a surgical treatment option for severe hidradenitis suppurativa Hurley stage II/III. (medscape.com)
Neutrophilic eccrine hidradenitis17
- 780 This group includes neutrophilic eccrine hidradenitis and recurrent palmoplantar hidradenitis. (wikipedia.org)
- Neutrophilic eccrine hidradenitis (NEH) was initially described in acute myelogenous leukemia (AML) patients undergoing chemotherapy. (medscape.com)
- Children may develop a palmoplantar variant of neutrophilic eccrine hidradenitis unassociated with underlying disease. (medscape.com)
- A skin biopsy specimen demonstrating characteristic pathologic changes of the eccrine glands is required to confirm a diagnosis of neutrophilic eccrine hidradenitis. (medscape.com)
- The mechanism(s) of neutrophilic eccrine hidradenitis (NEH) is unknown, although neutrophilic eccrine hidradenitis pathologic changes observed with intradermal bleomycin injections support a direct toxic effect of chemotherapy. (medscape.com)
- More than 70% of oncology patients who develop neutrophilic eccrine hidradenitis do so after their first course of chemotherapy. (medscape.com)
- Neutrophilic eccrine hidradenitis in young children may be triggered by thermal damage of eccrine glands. (medscape.com)
- The cause of neutrophilic eccrine hidradenitis (NEH) is unknown. (medscape.com)
- A direct toxic effect of chemotherapy and a paraneoplastic mechanism have both been proposed to explain neutrophilic eccrine hidradenitis in the context of malignancy. (medscape.com)
- Cases of neutrophilic eccrine hidradenitis resolving after withdrawal of chemotherapy and recurring upon reinstitution of the same regimen favor the former. (medscape.com)
- Also supporting a direct toxic drug response is a study showing that the intradermal injection of bleomycin can yield local neutrophilic eccrine hidradenitis changes. (medscape.com)
- The frequency of neutrophilic eccrine hidradenitis is unknown. (medscape.com)
- A slight male predominance is found in cases of neutrophilic eccrine hidradenitis. (medscape.com)
- Neutrophilic eccrine hidradenitis has been reported in individuals as young as 6 months and as old as 79 years. (medscape.com)
- Neutrophilic eccrine hidradenitis heralding the onset of acute myelogenous leukemia. (medscape.com)
- Gomez Vazquez M, Peteiro C, Toribio J. Neutrophilic eccrine hidradenitis heralding the onset of chronic myelogenous leukaemia. (medscape.com)
- Saada V, Aractingi S, Leblond V, Marinho E, Frances C, Chosidow O. [Neutrophilic eccrine hidradenitis associated with relapse of acute myeloblastic leukemia]. (medscape.com)
Living with Hidradenitis Suppurativa1
- BPT) - Approximately 1 in 100 people are believed to be living with hidradenitis suppurativa (HS), a chronic, often painful inflammatory skin condition that can become more severe over time, if not treated. (onlinemadison.com)
Management of hidradenitis suppurativa3
- The management of hidradenitis suppurativa is complex and should be undertaken on the basis of its objective severity and subjective impact on the patient. (medscape.com)
- How much do you know about the management of hidradenitis suppurativa? (medscape.com)
- Pathogenesis, clinical features and management of hidradenitis suppurativa. (medscape.com)
Suffering from Hidradenitis suppurativa2
- I was suffering from Hidradenitis suppurativa (HS) for almost 10 years. (earthclinic.com)
- Although the overall study did not meet statistical significance, izokibep appears to be demonstrating consistent early and high orders of response for patients suffering from hidradenitis suppurativa without safety or tolerability limitation," said Shao-Lee Lin, MD, PhD, CEO and founder of Acelyrin. (consultantlive.com)
Patients15
- Morbidity in patients with hidradenitis suppurativa. (medscape.com)
- Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. (medscape.com)
- A new study compared measures of bone metabolism between 81 patients with hidradenitis suppurativa and 79 age- and sex-matched controls. (medpagetoday.com)
- Patients with hidradenitis suppurativa are at a higher risk for chronic pulmonary disease, diabetes, and mild liver disease. (aad.org)
- The data showed all 20 patients treated with Upadacitinib achieved a 50% improvement in Hidradenitis Suppurativa Clinical Response (HiSCR 50) from baseline to week 12. (hcplive.com)
- Hidradenitis suppurativa has the highest impact on patients' quality of life among all assessed dermatologic conditions. (medscape.com)
- Tumor necrosis factor (TNF) inhibitors yield promising responses among patients with chronic, recurring-abscessing sweat-gland inflammation known as hidradenitis suppurativa (HS). (empr.com)
- WASHINGTON, DC -Tumor necrosis factor (TNF) inhibitors yield promising responses among patients with chronic, recurring-abscessing sweat-gland inflammation known as hidradenitis suppurativa (HS), according to research findings presented at the 2016 ACR/ARHP Annual Meeting. (empr.com)
- Results showed a significantly higher proportion of patients achieved a Hidradenitis Suppurativa Clinical Response (HiSCR) when treated with Cosentyx 300 mg, dosed every two weeks (after standard weekly loading doses), compared with placebo at Week 16 in both the SUNSHINE and SUNRISE trials (45.0% vs 33.7% [P=.0070] and 42.3% vs 31.2% [P=0.0149], respectively) 1 . (novartis.com)
- Earlier this year, bimekizumab was found to be an effective treatment for patients with hidradenitis suppurativa , according to the findings of a phase 3 trial. (hospitalhealthcare.com)
- The MIRA trial (M1095-HS-201), which recruited 234 patients, is the first randomized, double-blind, placebo-controlled trial to use Hidradenitis Suppurativa Clinical Response (HiSCR) 75 as its primary endpoint, a higher measure of clinical response versus the HiSCR50 measure used in other clinical trials, therefore representing a landmark milestone in HS clinical development. (pipelinereview.com)
- Hidradenitis suppurativa has never attracted so much attention before and the need for exchange of information and opinion has never been greater - which is good news for both - patients and researchers. (sidemast.org)
- HS Foundation is an organization dedicated to helping dermatologists better understand hidradenitis suppurativa (HS) so that their patients can receive optimal medical care and support. (ovillavet.com)
- The Hurley staging system is a widely used grading system to characterize the extent of disease in patients with hidradenitis suppurativa (HS). (hsdiseasesource.com)
- Patients exhibit increased susceptibility to cutaneous (furunculosis, skin abscesses, hidradenitis suppurativa) and systemic infections. (lu.se)
Acne11
- Hidradenitis suppurativa is a chronic inflammatory skin condition, considered a member of the acne family of disorders. (wikipedia.org)
- Some products for adult acne may help relieve some symptoms for people with hidradenitis, although there is no guarantee it will work in all or even most individuals. (wikipedia.org)
- Hidradenitis suppurativa" is acne inversa! (wikipedia.org)
- Hidradenitis suppurativa, also known as acne inversa, is a chronic skin disease characterized by recurrent boil-like lumps (nodules) under the skin. (medlineplus.gov)
- European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. (medscape.com)
- Hidradenitis suppurativa/acne inversa (HS) is a chronic inflammatory skin disease characterized by occlusion of hair follicles as a primary pathogenic factor. (nih.gov)
- The search terms were (prevalence OR incidence OR epidemiology) AND (hidradenitis suppurativa OR acne inversa OR Verneuil's disease). (nih.gov)
- Hidradenitis suppurativa, or acne inversa, is a chronic inflammatory skin disorder clinically characterized by acne-like skin lesions, follicular occlusion and recurrent inflammation. (novapublishers.com)
- Hidradenitis suppurativa (HS), also known as acne inversa, impairs quality of life (QOL) more than many other dermatological conditions , a new study shows. (ajmc.com)
- Hidradenitis suppurativa-or acne inversa-is a chronic inflammatory skin disease characterized by painful, deep nodules and abscesses that rupture and lead to scarring. (medscape.com)
- PASH syndrome (pyoderma gangrenosum, acne, and suppurative hidradenitis) forms part of the spectrum of autoinflammatory diseases. (cdlib.org)
Papules and Nodules1
- Multiple acneiform papules and nodules of hidradenitis suppurativa. (vulvovaginaldisorders.org)
Symptoms of hidradenitis4
- The signs and symptoms of hidradenitis suppurativa typically appear after puberty, usually in a person's teens or twenties, although they can begin earlier in puberty, particularly in affected females. (medlineplus.gov)
- One of the most visible symptoms of hidradenitis suppurativa is the scars that the condition can leave behind. (jshaoda.com)
- What are the symptoms of Hidradenitis Suppurativa? (thisisaaronslife.com)
- The symptoms of hidradenitis can vary from one person to the next. (thisisaaronslife.com)
20231
- Fast Five Quiz: Hidradenitis Suppurativa Management - Medscape - Jan 27, 2023. (medscape.com)
HiSCR1
- Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. (medscape.com)
Suppurativa prevalence1
- Hidradenitis suppurativa prevalence (with 95% CI) among the overall population and among subgroups. (nih.gov)
Suppurative hidradenitis1
- The unexpected efficacy of wide-spectrum antimicrobial treatments for HS highly suggests that these bacteria are partly causative agents for suppurative hidradenitis and should be considered to be treatment targets. (medscape.com)
Pyoderma gangrenosum1
- Recent findings Expanding off-label indications for IL-1 blockade include neutrophil-dominant skin diseases, including pyoderma gangrenosum, hidradenitis supperativa, and pustular psoriasis. (medscape.com)
Clinical3
- New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes. (medscape.com)
- Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study. (hcplive.com)
- Can clinical Subtypes of Hidradenitis Suppurativa lead to more individual treatment? (bpno.dk)
Skin21
- Mayo Clinic: Hidradenitis suppurativa support Birth Control Pills for Certain Female Skin-Related Issues Are there any effective natural skin treatment options? (wikipedia.org)
- However, this finding may be an underestimate because affected individuals do not always tell their family members that they have the condition, and hidradenitis suppurativa is sometimes misdiagnosed as other skin disorders. (medlineplus.gov)
- Hidradenitis suppurativa is a chronic disabling disorder of the terminal follicular epithelium in the apocrine gland-bearing skin. (medscape.com)
- Bacteria known to cause skin and soft tissue infections were uncovered in microbiological studies of the skin disease hidradenitis suppurativa (HS), with nearly 60% of cultures dominated by Staphylococcus lugdunensis , according to a study published online November 13 in Emerging Infectious Diseases . (medscape.com)
- Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition characterized by painful bumps in the skin. (healthline.com)
- Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease that primarily affects intertriginous zones, such as the armpits and groin. (medpagetoday.com)
- Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease marked by painful abscesses that develop in areas where there are large numbers of sweat glands. (sciencedaily.com)
- Exercising when you have hidradenitis suppurativa (HS), a chronic inflammatory skin condition, can be challenging. (everydayhealth.com)
- This week (June 5-11) is Hidradenitis Suppurativa (HS) Awareness Week, a moment when the HS community unites to raise awareness and show support for those around the world living with this debilitating skin condition. (ucb.com)
- Acelyrin's investigational IL-17A inhibitor-known as izokibep-did not meet its primary endpoint in a phase 2b/3 trial for chronic skin condition hidradenitis suppurativa (HS) , according to recent findings. (consultantlive.com)
- Hidradenitis suppurativa (HS) causes red, painful, draining bumps and tunnels in the skin. (hs-foundation.org)
- Hidradenitis suppurativa (HS) is a chronic skin disease with point prevalence between 1% and 4%, characterized by recurrent inflammation and painful formation of nodules in the intertriginous areas of the skin. (iasp-pain.org)
- Two distinct genetic loci that contribute to the risk of an individual developing the chronic skin condition hidradenitis suppurativa (HS) have been identified by researchers at the University of North Carolina (UNC). (hospitalhealthcare.com)
- Hidradenitis suppurativa (HS) is a skin disease characterized by recurrent nodules or abscesses and chronic suppurating lesions. (cdc.gov)
- Hidradenitis suppurativa is a chronic skin condition featuring pea- to marble-sized lumps under the skin. (middlesexhealth.org)
- Hidradenitis suppurativa (HS) is a highly prevalent, morbid inflammatory skin disease with limited treatment options. (jci.org)
- Hidradenitis Suppurativa (HS) is a skin condition. (ksandhs.com)
- Hidradenitis Suppurativa is an arising disease, characterized by the presence of painful lumps on the skin. (thisisaaronslife.com)
- Hidradenitis is a condition that causes small lumps under the skin. (thisisaaronslife.com)
- Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease that affects 1-4% of the population. (ovillavet.com)
- Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. (hsdiseasesource.com)
Supperativa1
- 710 Recent evidence supports that the primary event is follicular hyperkeratosis and obstruction, but the term hidradenitis supperativa has continued to be used in major medical journals. (wikipedia.org)
Sweat glands3
- Hidradenitis suppurativa is a chronic cutaneous condition originally thought to be primarily characterized by suppurative inflammation of the apocrine sweat glands. (wikipedia.org)
- Hidradenitis suppurativa: abscess of the apocrine sweat glands. (medscape.com)
- The Hidradenitis Suppurativa Clinic at the Rheumatology office with the GW Medical Faculty Associates defines HS as "a common chronic, recurrent inflammatory disease of the apocrine sweat glands. (ksandhs.com)
Blood donors1
- Cross-sectional study identifies lower risk of Staphylococcus aureus nasal colonisation in Danish blood donors with Hidradenitis suppurativa symptoms. (iasp-pain.org)
Fast Five Quiz1
- Fast Five Quiz: Hidradenitis Suppurativa - Medscape - Nov 05, 2019. (medscape.com)
Groin1
- Hidradenitis suppurativa is a chronic, scarring, acnelike inflammatory process that occurs in the axillae, groin, and around the nipples and anus. (msdmanuals.com)
Medscape1
- Cite this: Bacteria in Hidradenitis Suppurativa Support Antibiotic Use - Medscape - Nov 14, 2014. (medscape.com)
Infectious disease4
- Infectious Disease Screening Prior to Systemic Immunomodulatory Therapy in Hidradenitis Suppurativa: Consensus Guidelines from the Asia-Pacific Hidradenitis Suppurativa Foundation. (physiciansweekly.com)
- Current infectious disease screening recommendations for hidradenitis suppurativa (HS) are adopted from recommendations in chronic plaque psoriasis. (physiciansweekly.com)
- The presented consensus recommendations are the first specifically developed for pre-treatment infectious disease screening in Hidradenitis Suppurativa. (physiciansweekly.com)
- No, hidradenitis suppurativa is not an infectious disease. (thisisaaronslife.com)
Hurley1
- HS disease activity was assessed using Active Nodule count (AN count), Hurley Stage and Hidradenitis Sartorious Score (HSS). (empr.com)
Disease8
- Hidradenitis is any disease in which the histologic abnormality is primarily an inflammatory infiltrate around the eccrine glands. (wikipedia.org)
- One area of study looks at how what is going on in the gut's microbiome may positively or negatively affect the disease activity of a person with hidradenitis suppurativa (HS). (medicalnewstoday.com)
- As such, Hidradenitis Suppurativa: From Diagnosis to Treatment details specific operative nuances of affected locations and surgical approaches to localized, regional, and more systemic disease. (novapublishers.com)
- I have had this HS disease for about 16 years including a pilonidal cyst .The pilonidal cyst was treated 5 yrs ago with some herbs from a herbalist.The hidradenitis superetiva has gotten 95 % better because of the use of the Avocado bark. (earthclinic.com)
- Hidradenitis suppurativa (HS), a disease with a relatively dormant treatment space, may be soon inundated with systemic drugs of unique delivery and efficacy. (hcplive.com)
- AbbVie announces the launch of their hidradenitis suppurativa-centered educational website aimed at bringing awareness and educating physicians on the disease. (dermatologytimes.com)
- Hidradenitis is more likely to develop in someone who has Crohn's disease, diabetes, psoriasis or metabolic syndrome. (thisisaaronslife.com)
- Finally, we hope that the better understanding of the disease will also open the way for a broader collaboration with the non-dermatological community, based on the unique biological characteristics of Hidradenitis. (sidemast.org)
Surgical2
- Bohn J, Svensson H. Surgical treatment of hidradenitis suppurativa. (medscape.com)
- What happens after a single surgical intervention for hidradenitis suppurativa? (analysisgroup.com)
Treatment8
- Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 2: Treatment Options. (medscape.com)
- Suggestions form uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. (medscape.com)
- Tierney E, Mahmoud BH, Hexsel C, Ozog D, Hamzavi I. Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. (medscape.com)
- Treatment of hidradenitis suppurativa with a nonablative radiofrequency device. (medscape.com)
- In closing, the authors discuss evidence-based therapeutic approaches for the management and treatment of hidradenitis suppurativa and how, most commonly, a multimodal treatment plan is required for optimal response. (novapublishers.com)
- Are you familiar with the presentation, workup, and treatment of hidradenitis suppurativa? (medscape.com)
- Can a PDE4-inhibitor be the next approved drug for the treatment of hidradenitis suppurativa? (bpno.dk)
- Hidradenitis suppurative treatment goals are to prevent new lesions, reduce inflammation, and remove sinus tracts. (msdmanuals.com)
Scars1
- Scars, nodules, and cysts in right inguinal area in hidradenitis suppurativa. (vulvovaginaldisorders.org)
Onset1
- What causes the onset of Hidradenitis Suppurativa? (thisisaaronslife.com)
Primary endpoint1
- Acelyrin's investigational IL-17A inhibitor, izokibep, was not able to meet its primary endpoint in a phase 2b/3 study for hidradenitis suppurativa, with 39% of individiuals on once-weekly 160-mg izokibep having a 75% reduction in HiSCR75 score at the 16 week mark, compared to 29% on placebo. (consultantlive.com)
Quiz1
- These quiz questions about hidradenitis suppurativa (HS) are derived from current literature. (medpagetoday.com)